|
India News Releases
|
(India.CityRegions.Com, July 14, 2017 ) According to Publisher, the Global Antiviral market is accounted for $42.65 billion in 2016 and is expected to reach $63.11 billion by 2022 growing at a CAGR of 5.8%. Increased count of people across the globe affecting from influenza, respiratory syncytial virus and epidemic of viral infections had given market a prudential base for the growth. Strong R&D and newer & advance formulations in the antiviral drugs market are expected to drive the market. However, high risk of failure and huge cost of R&D are hampering the market.
For more information about this report: http://www.reportsweb.com/antiviral-drugs-global-market-outlook-2016-2022 HIV antivirals segment among applications is expected to dominate the market due to increase in prevalence of HIV infections, and due to growing awareness among people. Moreover, generic drugs segment is expected to witness lucrative growth over the forecast period on account of favorable government regulations. North American market is expected to dominate the global market. However, Asia Pacific is estimated to be the fastest growing region due to growing economies and increased healthcare expenditure in the region.
Some of the key players of the Antiviral Drugs market include Abbott Laboratories, AbbVie, Inc., Aurobindo Pharma, Bristol-Myers-Squibb, Cipla, Dr. Reddy's Laboratories Ltd., F. Hoffmann-La Roche AG, Gilead Sciences, GlaxoSmithKline plc., Johnson and Johnson, MedImmune/AstraZeneca, Merck & Co., Mylan N.V., Roche Diagnostics, Schering-Plough and Teva Pharmaceutical Industries Ltd.
Applications Covered: -Hepatitis-B antivirals -Hepatitis-C antivirals -Herpes virus -HIV antivirals -Influenza -Other Applications -Pneumonia -Flu
End-Users Covered: -Ambulatory Surgical Centers -Clinics -Hospitals
Distribution Channels covered: -Hospital Pharmacy Store -Online Pharmacy -Retail Pharmacy Store
Product Types Covered: -Generic Drugs -Branded Drugs
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001716560/sample
Action Mechanisms covered: -Nucleotide polymerase inhibitor -Protease inhibitors -Reverse transcriptase inhibitors -Other Action Mechanisms
Regions Covered: -North America -US -Canada -Mexico -Europe -Germany -France -Italy -UK -Spain -Rest of Europe -Asia Pacific -Japan -China -India -Australia -New Zealand -Rest of Asia Pacific -Rest of the World -Middle East -Brazil -Argentina -South Africa -Egypt
Company Profiling 12.1 Abbott Laboratories 12.2 AbbVie, Inc. 12.3 Aurobindo Pharma 12.4 Bristol-Myers-Squibb 12.5 Cipla 12.6 Dr. Reddy's Laboratories Ltd 12.7 F. Hoffmann-La Roche AG 12.8 Gilead Sciences 12.9 GlaxoSmithKline plc. 12.10 Johnson and Johnson 12.11 MedImmune/AstraZeneca 12.12 Merck & Co 12.13 Mylan N.V. 12.14 Roche Diagnostics 12.15 Schering-Plough 12.16 Teva Pharmaceutical Industries Ltd.
Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001716560/buying
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
|
|
|
India RSS Feed Marketpalce
|
India News Headlines
Daily news from India: arts, business, culture, politics, science, technology & more.
Free Sales & Marketing Magazines
Get free publications about marketing, sales and customer relations management.
Submit RSS feed on India. Have your feed on news, products or services displayed under this marketpalce and have your feed on a full page updated daily.
|
|
India Business News by Major Cities
|
|
|
Listen to GroupWeb Radio
INDIA BUSINESS TV
|